The estimated Net Worth of Frank Kung is at least $85.1 Milion dollars as of 15 September 2022. Frank Kung owns over 3,298,776 units of Amyris Inc stock worth over $5,473 and over the last 7 years he sold AMRS stock worth over $85,061,512. In addition, he makes $58,126 as Independent Director at Amyris Inc.
Sign up
Frank Kung AMRS stock SEC Form 4 insiders trading
Frank has made over 6 trades of the Amyris Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 600,000 units of AMRS stock worth $2,142,000 on 20 September 2022.
The largest trade he's ever made was exercising 6,673,291 units of Amyris Inc stock on 17 August 2018 worth over $29,229,015. On average, Frank trades about 992,659 units every 75 days since 2017. As of 15 September 2022 he still owns at least 109,460 units of Amyris Inc stock.
You can see the complete history of Frank Kung stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Frank Kung biography
Dr. Frank F. C. Kung Ph.D. serves as Independent Director of the Company. Dr. Kung is a founding member of Vivo Capital LLC (“Vivo”), a healthcare focused investment firm founded in 1996 in Palo Alto, California, whose fund under management is an owner of greater than five percent of the Company’s outstanding common stock. Dr. Kung started his career in the biotechnology industry in 1979 when he joined Cetus Corporation. He later co-founded Cetus Immune Corporation in 1981, which was acquired by its parent company in 1983. In 1983, he co-founded Genelabs Technologies, Inc. where he served as Chairman and CEO until 1995. During his tenure in Genelabs, he brought the company public in 1991, and built it to a 175 employee international biotech company with operations in the United States, Belgium, Singapore, Switzerland and Taiwan. Dr. Kung holds a Bachelor of Science degree in chemistry from the National Tsing Hua University in Taiwan, and a Doctor of Philosophy degree in molecular biology and a Master of Business Administration degree from the University of California, Berkeley.
What is the salary of Frank Kung?
As the Independent Director of Amyris Inc, the total compensation of Frank Kung at Amyris Inc is $58,126. There are 13 executives at Amyris Inc getting paid more, with John G. Melo having the highest compensation of $1,344,913.
How old is Frank Kung?
Frank Kung is 71, he's been the Independent Director of Amyris Inc since 2017. There are 1 older and 19 younger executives at Amyris Inc. The oldest executive at Amyris Inc is Patrick Yang, 72, who is the Independent Director.
What's Frank Kung's mailing address?
Frank's mailing address filed with the SEC is C/O AMYRIS, INC., 5885 HOLLIS STREET, SUITE 100, EMERYVILLE, CA, 94608.
Insiders trading at Amyris Inc
Over the last 14 years, insiders at Amyris Inc have traded over $118,642,007 worth of Amyris Inc stock and bought 100,049,915 units worth $258,812,433 . The most active insiders traders include Gas & Power Usa, Sas Total, L John Doerr oraz Philippe Boisseau. On average, Amyris Inc executives and independent directors trade stock every 25 days with the average trade being worth of $65,903. The most recent stock trade was executed by Hermanus Kieftenbeld on 2 June 2023, trading 20,999 units of AMRS stock currently worth $19,949.
What does Amyris Inc do?
amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules, specialty ingredients and consumer products. the company is delivering its no compromise® products in focused markets, including specialty and performance chemicals, fragrance ingredients, and cosmetic emollients. more information about the company is available at www.amyris.com.
What does Amyris Inc's logo look like?
Complete history of Frank Kung stock trades at Amyris Inc
Amyris Inc executives and stock owners
Amyris Inc executives and other stock owners filed with the SEC include:
-
John G. Melo,
Pres, CEO & Director -
John Melo,
President, Chief Executive Officer, Director -
Nicole Kelsey,
General Counsel, Secretary -
Eduardo Alvarez,
Chief Operating Officer -
Hermanus Kieftenbeld,
CFO & Chief Admin. Officer -
Eduardo Alvarez,
Chief Operating Officer -
Kathleen Valiasek,
Chief Business Officer -
Nicole Kelsey,
Gen. Counsel & Sec. -
Geoffrey Duyk,
Independent Interim Chairman of the Board -
Carole Piwnica,
Independent Director -
Steven Mills,
Independent Director -
John Doerr,
Independent Director -
Patrick Yang,
Independent Director -
Frank Kung,
Independent Director -
Philip Eykerman,
Director -
James McCann,
Independent Director -
Christoph Goppelsroeder,
Director -
Lisa Qi,
Independent Director -
Peter DeNardo,
Director, Investor Relations and Corporate Communications -
Julie Washington,
Director -
Sheila Pollak,
Chief Marketing Officer - Biossance -
Han Kieftenbeld,
Chief Financial Officer -
Jim Iacoponi,
Sr. VP of Nutrition Ingredients -
Caroline Hadfield,
Pres of Aprinnova -
Charles Kraft,
Sr. VP of Global Manufacturing & Process Devel. -
Christine Ofori,
Chief People Officer -
Anthony Hughes,
Chief Accounting Officer -
(Mauritius) Pte Ltd Cairnhi...,
-
Gas & Power Usa, Sas Total,
Director -
Joel Cherry,
President of R&D -
L John Doerr Ann Howland Va...,
-
Fernando De Castro Reinach,
Director -
Abraham Klaeijsen,
Director -
Thani Sheikh Abdullah Bin K...,
Director -
R Neil Williams,
Director -
Hermanus Kieftenbeld,
CFO AND INTERIM CEO -
Ana Dutra,
-
International B.V.Koninklij...,
-
Tina Maloney,
Chief Accounting Officer -
Raffinage Chimie Total,
Director -
James Young Richardson,
SVP, Vert Markets and Sales Op -
Nicholas Khadder,
General Counsel and Secretary -
Philippe Boisseau,
Director -
Mary Margaret Hastings Geor...,
Director -
Raffi Asadorian,
Chief Financial Officer -
(Mauritius) Pte Ltd Cairnhi...,
-
Ralph Alexander,
Director -
Jeryl L Hilleman,
Chief Financial Officer -
Perkins Caufield & Byers Xi...,
10% owner -
Peter Boynton,
Chief Commercial Officer -
Jefferson Lievense,
SVP, Process Dev. & Mfg. -
Keith Kinkead Reiling,
Director -
Xii Associates, Llc Kpcb,
10% owner -
Xii Founders Fund, Llc Kpcb,
10% owner -
Mario Portela,
Chief Operating Officer -
Tamara Tompkins,
SVP, Gen??l Counsel & Sec??ty -
Patrick Pichette,
Director -
Ventures Ii, L.P.Khosla Ven...,
-
Karen Weaver,
Principal Accounting Officer -
Neil Renninger,
Chief Technical Officer -
Samir Kaul,
Director -
(Mauritius) Pte Ltd Temasek...,
-
Arthur D Levinson,
Director -
Gary Loeb,
SVP, Gen'l Counsel & Secretary -
Paulo Sergio De Oliveira Diniz,
CEO, Amyris Brasil S.A. -
Susanna Mcferson,
CHIEF BUSINESS OFFICER -
Nam Hai Dr Chua,
Director -
Anthony Hughes,
CHIEF ACCOUNTING OFFICER -
Ryan Panchadsaram,
-
Elizabeth E. Dreyer,
CHIEF ACCOUNTING OFFICER -
L John Foris Ventures, Llc ...,